Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CStone Pharmaceuticals
  6. News
  7. Summary
    2616   KYG2588M1006

CSTONE PHARMACEUTICALS

(2616)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

CStone Pharmaceuticals : Says New Drug Shows Efficacy in Treating Lung Cancer With RET Fusion

09/08/2021 | 09:31pm EDT


ę MT Newswires 2021
All news about CSTONE PHARMACEUTICALS
10/08CSTONE PHARMACEUTICALS : presents research data of CS5001 (ROR1 ADC) at the 33rd AACR-NCI-..
AQ
10/07CSTONE PHARMACEUTICALS : Achieves Potential Antitumor Activity From Preclinical Antibody T..
MT
10/01CStone Presents Arrow Study Data for GAVRETO« (Pralsetinib) in Chinese Patients with Re..
CI
09/28CSTONE PHARMACEUTICALS : announced that the research data of CS5001 (ROR1 ADC) has been se..
AQ
09/21CSTONE PHARMACEUTICALS : Pharma Presents Cancer Drug's Bridging Study Data at Oncology Con..
MT
09/20CSTONE PHARMACEUTICALS : presents preliminary results from a phase Ib study of the anti-CT..
AQ
09/20CStone Pharmaceuticals Presents Clinical Data from the China Registrational Bridging St..
CI
09/19CSTONE PHARMACEUTICALS' : Investigational Cancer Treatment Shows Potential in Phase 1b Tri..
MT
09/18Cstone Presents Preliminary Results from Phase Ib Study of the Anti-Ctla-4 Monoclonal A..
CI
09/17EQRx and its Partner CStone Pharmaceuticals Announce Presentation of Phase 3 Data Demon..
CI
More news
Financials
Sales 2021 271 M 42,1 M 42,1 M
Net income 2021 -1 829 M -284 M -284 M
Net cash 2021 1 635 M 254 M 254 M
P/E ratio 2021 -5,95x
Yield 2021 -
Capitalization 9 476 M 1 472 M 1 473 M
EV / Sales 2021 29,0x
EV / Sales 2022 6,27x
Nbr of Employees 573
Free-Float 75,2%
Chart CSTONE PHARMACEUTICALS
Duration : Period :
CStone Pharmaceuticals Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CSTONE PHARMACEUTICALS
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 8,15 CNY
Average target price 14,73 CNY
Spread / Average Target 80,8%
EPS Revisions
Managers and Directors
Ning Jun Jiang Chairman & Chief Executive Officer
Jian Xin Yang Chief Medical Officer & Senior Vice President
Xin Zhong Wang Chief Scientific Officer & Senior Vice President
Ting Yuk Wu Independent Non-Executive Director
Hong Bin Sun Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
CSTONE PHARMACEUTICALS-2.28%1 472
GILEAD SCIENCES, INC.16.08%84 795
WUXI APPTEC CO., LTD.29.45%66 184
BIONTECH SE203.83%59 820
REGENERON PHARMACEUTICALS14.52%57 519
VERTEX PHARMACEUTICALS-23.09%47 156